To assess the role of NAT10 in pancreatic cancer, cell lines with high NAT10 expression (PANC-1 and AsPC-1) and low NAT10 expression (CFPAC-1 and MIA PaCa-2) were selected. The gene discussed is NAT10; the disease is pancreatic neoplasm.